for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Health

Roche presents new data on efficacy of MS treatment Ocrevus

FILE PHOTO: Workers clean the windows of a building of Roche in Rotkreuz May 27, 2020. REUTERS/Arnd Wiegmann/File Photo

ZURICH (Reuters) - Roche said on Thursday new data showed its big-selling multiple sclerosis treatment Ocrevus was a “highly effective treatment option offering a favourable and consistent benefit risk profile”.

The data will be presented at MSVirtual2020 from Sept. 11-13, Roche said in a statement.

It will also present data showing its Enspryng treatment lowered relapse severity in people with Neuromyelitis Optica Spectrum Disorder (NMOSD).

Reporting by Silke Koltrowitz; editing by Thomas Seythal

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up